There have been several reports on RASSF1 promoter hypermethylation in thyroid tumors (Xing et al., 2004; Schagdarsurengin et al., 2002) including comparisons between FTCs and their corresponding normal tissues utilizing non-quantitative methods such as MSP. This evidence concerns the gene RASSF1 and thyroid tumor.